OpenVSafe by OpenVAERS
Search V-safe

ZDA-32420-52573

3 vaccinations 14 coded responses 23 check-ins 14 free-text entries 8 call cases
Sex
Female
Age at first dose
41-45
ZIP prefix
481 / MI
Registered
2020-12-30
Relationship
Self
Race
Native Hawaiian or other Pacific Islander
Ethnicity
Not Hispanic or Latino
Registered dependents
CN2-20077-59600 Child or adolescent in my care · Female · 2022-04-21

Timeline

  1. 2020-12-30
    Registered in v-safe
  2. 2020-12-30
    Dose 1 — Pfizer-BioNTech
  3. 2020-12-30
    Health check-in — day 0, dose 1
    Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  4. 2020-12-30
    Report sent to call center — day 0, dose 1
    Be unable to do your normal daily activities
    1 call case(s)
  5. 2020-12-31
    Survey response — days 1–6 daily, dose 1
    MedDRA: Ageusia, Anosmia — Feeling: Poor · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work, Be unable to do your normal daily activities
    Free text: Loss of taste and smell
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2020-12-31
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to work · Be unable to do your normal daily activities
    1 call case(s)
  7. 2021-01-01
    Survey response — days 1–6 daily, dose 1
    MedDRA: Dizziness, Feeling abnormal — Feeling: Poor · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Dizziness and head fog
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-01-01
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to do your normal daily activities
    1 call case(s)
  9. 2021-01-03
    Survey response — days 1–6 daily, dose 1
    MedDRA: Brain fog, COVID-19 screening, Dizziness, Feeling abnormal, SARS-CoV-2 test — Feeling: Poor · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional
    Free text: Systemic reaction (other): Dizziness and head fog · Healthcare visit (other): Screened for COVID-19
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-01-03
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  11. 2021-01-04
    Survey response — days 1–6 daily, dose 1
    MedDRA: Dizziness, Peripheral coldness, Thinking abnormal, Vision blurred — Feeling: Fair · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Free text: Dizziness, unclear vision/thinking, cold feet and hands
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-01-04
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to work · Be unable to do your normal daily activities
    1 call case(s)
  13. 2021-01-09
    Survey response — day 7, dose 1
    MedDRA: Dizziness, Feeling abnormal — Feeling: Fair · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Dizziness and head fog
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-01-09
    Report sent to call center — day 7, dose 1
    Be unable to do your normal daily activities
    1 call case(s)
  15. 2021-01-14
    Health check-in — day 14, dose 1
    Feeling: Fair
    Adult check-in
  16. 2021-01-20
    Survey response — day 21, dose 1
    MedDRA: Migraine — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Migraine
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-01-22
    Dose 2 — Pfizer-BioNTech
  18. 2021-01-23
    Survey response — days 1–6 daily, dose 2
    MedDRA: Dizziness — Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches
    Free text: Dizziness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2021-01-24
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Fever · Chills, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  20. 2021-01-25
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  21. 2021-01-27
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Fever · Chills, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site
    Adult check-in
  22. 2021-01-28
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  23. 2021-01-28
  24. 2021-02-01
    Health check-in — day 7, dose 2
    Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  25. 2021-02-06
    Health check-in — day 14, dose 2
    Feeling: Fair
    Adult check-in
  26. 2021-02-12
    Survey response — day 21, dose 2
    MedDRA: Headache — Feeling: Good
    Free text: Headache
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  27. 2021-02-20
    Survey response — day 28, dose 2
    MedDRA: Migraine — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Migraine headaches
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  28. 2021-02-26
    Survey response — day 35, dose 2
    MedDRA: Fatigue, Headache, Oropharyngeal pain — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Fatigue, headache, sore throat
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  29. 2021-03-07
    Survey response — day 42, dose 2
    MedDRA: Headache, Oropharyngeal pain — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Sore throat and headache.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  30. 2021-04-23
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  31. 2021-07-23
    Survey response — 6 months, dose 2
    MedDRA: Insomnia, Oropharyngeal pain — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Sore throat. Sleeplessness.
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  32. 2021-07-23
    Report sent to call center — 6 months, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  33. 2021-07-26
  34. 2021-11-30
    Dose 3 — Pfizer-BioNTech
  35. 2022-01-22
    Survey response — 12 months, dose 2
    MedDRA: Arthralgia, Brain fog, Chest discomfort, Cough, Eye pain, Fatigue, Feeling cold, Hypogeusia, Hyposmia — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Fatigue, head fog, eye pain, hip pain, feeling cold, reduced sense of taste and smell, cough and chest heaviness.
    MedDRA releases: 2024-11 · check-in free text available
  36. 2022-01-22
    Report sent to call center — 12 months, dose 2
    Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  37. 2022-01-24
    Call successful
    Not applicable (accidental reporting or does not believe symptoms are related to vaccine)
  38. 2022-12-03
    Survey response — 12 months, dose 3
    MedDRA: Cough, Fatigue, Myalgia, Oropharyngeal pain — Feeling: Fair
    Free text: Sore throat cough and fatigue myalgias
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12020-12-30Pfizer-BioNTech
22021-01-22Pfizer-BioNTech
32021-11-30Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2020-12-30 Unsuccessful
2020-12-31 Unsuccessful
2021-01-01 Unsuccessful
2021-01-03 Successful Not applicable (accidental reporting or does not believe symptoms are related to vaccine)
2021-01-04 Unsuccessful
2021-01-09 Unsuccessful
2021-07-23 Successful Not applicable (accidental reporting or does not believe symptoms are related to vaccine)
2022-01-22 Successful
2022-01-24
Not applicable (accidental reporting or does not believe symptoms are related to vaccine)

Free text

Release 1 — days 1–6 daily, dose 1

2020-12-31

Systemic reaction (other): Loss of taste and smell

2021-01-01

Systemic reaction (other): Dizziness and head fog

2021-01-03

Systemic reaction (other): Dizziness and head fog
Healthcare visit (other): Screened for COVID-19

2021-01-04

Systemic reaction (other): Dizziness, unclear vision/thinking, cold feet and hands

Release 1 — day 7, dose 1

2021-01-09

Systemic reaction (other): Dizziness and head fog

Release 2 — day 21, dose 1

2021-01-20

Symptoms: Migraine

Release 2 — days 1–6 daily, dose 2

2021-01-23

Systemic reaction (other): Dizziness

Release 4 — day 21, dose 2

2021-02-12

Symptoms: Headache

Release 4 — day 28, dose 2

2021-02-20

Symptoms: Migraine headaches

Release 4 — day 35, dose 2

2021-02-26

Symptoms: Fatigue, headache, sore throat

Release 5 — day 42, dose 2

2021-03-07

Symptoms: Sore throat and headache.

Release 9 — 6 months, dose 2

2021-07-23

Symptoms: Sore throat. Sleeplessness.

Release 11 — 12 months, dose 2

2022-01-22

Symptoms: Fatigue, head fog, eye pain, hip pain, feeling cold, reduced sense of taste and smell, cough and chest heaviness.

Release 12 — 12 months, dose 3

2022-12-03

Symptoms: Sore throat cough and fatigue myalgias

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOCOVID-19 screening ○ ✓ ○
HCVOSARS-CoV-2 test ✓ ○ ✓
SDArthralgia · · ✓
SDBrain fog · · ✓
SDChest discomfort · · ✓
SDCough · · ✓
SDEye pain · · ✓
SDFatigue ✓ ✓ ✓
SDFeeling cold · · ✓
SDHeadache ✓ ✓ ✓
SDHypogeusia · · ✓
SDHyposmia · · ✓
SDInsomnia ✓ · ✓
SDMigraine ✓ ✓ ✓
SDMyalgia · · ✓
SDOropharyngeal pain ✓ ✓ ✓
SROAgeusia ✓ ✓ ✓
SROAnosmia ✓ ✓ ✓
SROBrain fog ✓ · ✓
SRODizziness ✓ ✓ ✓
SROFeeling abnormal ✓ ✓ ✓
SROPeripheral coldness ✓ ✓ ✓
SROSARS-CoV-2 test ○ ○ ○
SROThinking abnormal ✓ ✓ ✓
SROVision blurred ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release